A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

Clinical trial NCT06979596 · RECRUITING

Trial details

NCT number: NCT06979596
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Neoplasm

Start date: 2025-08-11
Primary completion: 2027-11-04
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.